12 results
Keyword Ketorolac Accord Remove keyword
Type of content
News Remove News filter
Patient safety
Yes Remove Yes filter
-
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023professionals will be revised accordingly. Information for patients … -
List item
Press release: Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B
CHMP, Last updated: 16/12/2016be monitored and managed according to current clinical guidelines … be monitored and managed according to current clinical guidelines … be monitored and managed according to current clinical guidelines … -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020EMA/229267/2020 Generic Capecitabine Accord: EPAR Capecitabine Medac … -
List item
Press release: Updated measures for pregnancy prevention during retinoid use
CHMP, Last updated: 23/03/2018the skin, must be used in accordance with the conditions of a … the skin, must be used in accordance with the conditions of a … isotretinoin must be used in accordance with the conditions of a … -
List item
Press release: European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)
CHMP, Last updated: 21/11/2014Corlentor/Procoralan will be updated accordingly. … -
List item
Press release: European Medicines Agency completes review of polymyxin-based medicines
CHMP, Last updated: 24/10/2014given. Doses should be reduced according to creatinine clearance in … Doses should be reduced according to creatinine clearance in … IU twice daily, adjusted according to the severity of the condition … -
List item
Press release: Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted – CHMP endorses PRAC recommendation
CHMP, Last updated: 23/05/2014RAS-acting agents will be amended accordingly. References: 1. Yusuf S, Teo … RAS-acting agents will be amended accordingly. References. 1. Yusuf … -
List item
Press release: EMA recommends measures to ensure safe use of Keppra oral solution
CHMP, Last updated: 14/10/2016is expected to take action according to the recommendations. List … pharmaceutical form of Keppra according to the age, weight and dose … pharmaceutical form of Keppra according to the age, weight and dose … -
List item
Press release: GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies
CHMP, Last updated: 23/01/2015 -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021this vaccine should be in accordance with official recommendations … -
List item
News: AstraZeneca’s COVID-19 vaccine: benefits and risks in context
CHMP, Last updated: 23/04/2021this vaccine should be in accordance with official recommendations … -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
CHMP, Last updated: 14/04/202109/04/2021 20:10 (UTC+02) in accordance with article 11 of Commission …